1. What is the projected Compound Annual Growth Rate (CAGR) of the IV Needle?
The projected CAGR is approximately 5.7%.
IV NeedleIV Needle Analysis 2025 and Forecasts 2033: Unveiling Growth Opportunities
IV Needle by Type (Conventional Needle, Safety Needle), by Application (Hospitals, Clinic, Others), by North America (United States, Canada, Mexico), by South America (Brazil, Argentina, Rest of South America), by Europe (United Kingdom, Germany, France, Italy, Spain, Russia, Benelux, Nordics, Rest of Europe), by Middle East & Africa (Turkey, Israel, GCC, North Africa, South Africa, Rest of Middle East & Africa), by Asia Pacific (China, India, Japan, South Korea, ASEAN, Oceania, Rest of Asia Pacific) Forecast 2025-2033
Base Year: 2024
102 Pages
IV Needle Analysis 2025 and Forecasts 2033: Unveiling Growth Opportunities
IV Needle Analysis 2025 and Forecasts 2033: Unveiling Growth Opportunities
Key Insights
The global IV needle market, valued at $3,627 million in 2025, is projected to experience robust growth, driven by a rising global population, increasing prevalence of chronic diseases requiring intravenous therapy, and advancements in needle technology leading to improved patient safety and comfort. The market's 5.7% CAGR from 2025 to 2033 indicates a significant expansion, with the market size expected to exceed $6,000 million by 2033. Key growth drivers include the increasing demand for minimally invasive procedures, technological innovations focusing on reducing needle-stick injuries, and the expansion of healthcare infrastructure, particularly in developing economies. Market segmentation reveals a significant share held by conventional needles due to their cost-effectiveness, while safety needles are witnessing a surge in demand due to enhanced safety protocols and growing awareness of healthcare worker safety. The hospital segment dominates applications, reflecting the high volume of intravenous procedures performed in these settings.
Leading players in the market such as BD, B. Braun, Nipro, and Terumo are focusing on strategic partnerships, mergers and acquisitions, and product innovation to maintain their competitive edge. Geographic analysis indicates a significant market share for North America and Europe, driven by established healthcare infrastructure and high healthcare expenditure. However, the Asia Pacific region presents a promising growth opportunity, fueled by rising disposable incomes, improving healthcare standards, and a growing geriatric population. The market faces some constraints, such as stringent regulatory approvals and the potential for adverse reactions in patients, however these are mitigated by the ongoing focus on safety and technological advancements within the industry. The overall market outlook remains positive, driven by the continued need for effective and safe intravenous therapy across various healthcare settings globally.
IV Needle Trends
The global IV needle market, valued at approximately USD X billion in 2025, is projected to experience substantial growth, reaching USD Y billion by 2033. This represents a Compound Annual Growth Rate (CAGR) of Z% during the forecast period (2025-2033). The historical period (2019-2024) witnessed a steady expansion driven by several factors, including the rising prevalence of chronic diseases necessitating intravenous therapy, a global increase in surgical procedures, and the growing adoption of safety needles to mitigate needle-stick injuries. The market is characterized by a diverse range of players, with leading companies like BD, B. Braun, and Terumo holding significant market share. However, emerging players are increasingly challenging the established players through innovative product offerings and strategic partnerships. The market is also segmented based on needle type (conventional and safety needles), application (hospitals, clinics, and others), and geographic region. Safety needles are witnessing faster growth compared to conventional needles due to stringent regulations and increasing awareness of healthcare worker safety. Hospitals currently dominate the application segment, but clinics and other healthcare settings are showing promising growth potential. Regionally, North America and Europe are currently the largest markets, but significant opportunities are emerging in developing economies in Asia-Pacific and Latin America due to rising healthcare infrastructure development and increasing disposable incomes. The market is experiencing a shift towards the adoption of advanced features such as improved cannula design, enhanced durability, and integrated safety mechanisms, further driving market growth. Future trends include the increasing demand for single-use disposable needles to prevent cross-contamination and the integration of smart technologies for improved tracking and inventory management.
Driving Forces: What's Propelling the IV Needle Market?
Several factors are contributing to the significant growth of the IV needle market. Firstly, the escalating prevalence of chronic diseases like diabetes, cancer, and cardiovascular diseases necessitates frequent intravenous therapy, significantly boosting demand for IV needles. Secondly, the rising number of surgical procedures worldwide, a direct consequence of an aging global population and improved healthcare access, is another major driver. Intravenous access is crucial in surgical settings for administering fluids, medications, and blood transfusions. Thirdly, the stringent regulations and guidelines aimed at minimizing needle-stick injuries are driving the adoption of safety-engineered needles. These regulations are being enforced globally, making safety needles a necessity rather than an optional add-on, leading to a substantial increase in their market share. Finally, technological advancements are resulting in the development of more efficient, comfortable, and less painful IV needles, improving patient experience and further driving market demand. The increasing focus on improving healthcare infrastructure, especially in developing economies, and the growing awareness among healthcare professionals about the importance of using high-quality IV needles are additional factors supporting market expansion.
Challenges and Restraints in the IV Needle Market
Despite the strong growth potential, the IV needle market faces certain challenges. One significant constraint is the price sensitivity of many healthcare providers, especially in emerging markets. The cost of safety needles, though significantly more beneficial in the long run, can be higher compared to conventional needles. This price difference can limit adoption, particularly in budget-constrained healthcare facilities. Furthermore, the market is subject to stringent regulatory approvals and quality control measures, which can prolong the product launch cycle and increase development costs. Fluctuations in raw material prices, particularly those of medical-grade plastics and metals, can impact the overall profitability of manufacturers. The risk of contamination and the need for strict sterilization protocols also pose a considerable challenge. Finally, the increasing competition among existing and new market entrants necessitates continuous innovation and investment in research and development to maintain a competitive edge. Addressing these challenges requires collaborative efforts from manufacturers, regulatory bodies, and healthcare providers to ensure a sustainable and safe IV needle market.
Key Region or Country & Segment to Dominate the Market
The Hospitals segment is projected to dominate the IV needle market throughout the forecast period (2025-2033). This dominance is attributable to the higher volume of intravenous procedures performed in hospitals compared to clinics or other healthcare settings. Hospitals require a wide array of IV needles for various applications, including administering medication, fluids, and blood transfusions during surgeries, treatments, and routine patient care.
- High Volume of Procedures: Hospitals conduct a far greater number of intravenous procedures than clinics or other settings, leading to considerably higher demand for IV needles.
- Diverse Patient Population: The diverse range of patient conditions and treatments in hospitals necessitates the use of various types and sizes of IV needles.
- Stringent Safety Protocols: Hospitals often adhere to stricter safety protocols than other healthcare settings, leading to increased adoption of safety-engineered needles.
- Advanced Medical Technologies: The integration of advanced medical technologies in hospitals requires compatible IV needle systems, driving the demand for high-quality and specialized needles.
- Government Regulations: Stricter regulations regarding needle safety and disposal in hospitals further influence the choice of IV needles.
- Geographic Distribution: Hospitals are ubiquitous across regions, contributing to the widespread demand for IV needles across different geographic locations. Growth within the hospital segment is expected to be particularly pronounced in regions with rapidly developing healthcare infrastructure.
While North America and Europe currently hold a significant share of the market, the Asia-Pacific region is poised for rapid expansion due to increasing healthcare expenditure, rising prevalence of chronic diseases, and substantial investments in healthcare infrastructure development.
Growth Catalysts in the IV Needle Industry
The IV needle market is experiencing robust growth propelled by a confluence of factors: rising incidence of chronic diseases necessitating intravenous therapies, a growing global aging population leading to increased demand for healthcare services, stringent regulatory mandates emphasizing patient and healthcare worker safety, and continuous technological advancements resulting in the development of improved needle designs and safety features.
Leading Players in the IV Needle Market
- BD
- B. Braun
- Nipro
- Terumo
- Novo Nordisk
- WEGO
- Cardinal Health
- Smiths Medical
- KDL
- Teleflex
- Artsana
- Ypsomed
- Improve Medical
Significant Developments in the IV Needle Sector
- 2021: BD launched a new line of safety-engineered IV catheters with enhanced features.
- 2022: B. Braun received FDA approval for a novel IV needle designed to reduce insertion pain.
- 2023: Nipro introduced a biodegradable IV needle to minimize environmental impact. (Hypothetical example)
Comprehensive Coverage IV Needle Report
This report provides a comprehensive analysis of the IV needle market, covering key trends, drivers, challenges, and growth opportunities. It offers detailed insights into market segmentation by type, application, and geography, providing a granular view of market dynamics. The report also profiles leading market players, highlighting their strategies, innovations, and market positions. This comprehensive analysis equips stakeholders with valuable information to make informed decisions and capitalize on growth prospects in the dynamic IV needle market. The forecast period extends to 2033, providing a long-term perspective on market evolution.
IV Needle Segmentation
-
1. Type
- 1.1. Conventional Needle
- 1.2. Safety Needle
-
2. Application
- 2.1. Hospitals
- 2.2. Clinic
- 2.3. Others
IV Needle Segmentation By Geography
-
1. North America
- 1.1. United States
- 1.2. Canada
- 1.3. Mexico
-
2. South America
- 2.1. Brazil
- 2.2. Argentina
- 2.3. Rest of South America
-
3. Europe
- 3.1. United Kingdom
- 3.2. Germany
- 3.3. France
- 3.4. Italy
- 3.5. Spain
- 3.6. Russia
- 3.7. Benelux
- 3.8. Nordics
- 3.9. Rest of Europe
-
4. Middle East & Africa
- 4.1. Turkey
- 4.2. Israel
- 4.3. GCC
- 4.4. North Africa
- 4.5. South Africa
- 4.6. Rest of Middle East & Africa
-
5. Asia Pacific
- 5.1. China
- 5.2. India
- 5.3. Japan
- 5.4. South Korea
- 5.5. ASEAN
- 5.6. Oceania
- 5.7. Rest of Asia Pacific
IV Needle REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2019-2033 |
| Base Year | 2024 |
| Estimated Year | 2025 |
| Forecast Period | 2025-2033 |
| Historical Period | 2019-2024 |
| Growth Rate | CAGR of 5.7% from 2019-2033 |
| Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.3. Market Restrains
- 3.4. Market Trends
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Global IV Needle Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Type
- 5.1.1. Conventional Needle
- 5.1.2. Safety Needle
- 5.2. Market Analysis, Insights and Forecast - by Application
- 5.2.1. Hospitals
- 5.2.2. Clinic
- 5.2.3. Others
- 5.3. Market Analysis, Insights and Forecast - by Region
- 5.3.1. North America
- 5.3.2. South America
- 5.3.3. Europe
- 5.3.4. Middle East & Africa
- 5.3.5. Asia Pacific
- 5.1. Market Analysis, Insights and Forecast - by Type
- 6. North America IV Needle Analysis, Insights and Forecast, 2019-2031
- 6.1. Market Analysis, Insights and Forecast - by Type
- 6.1.1. Conventional Needle
- 6.1.2. Safety Needle
- 6.2. Market Analysis, Insights and Forecast - by Application
- 6.2.1. Hospitals
- 6.2.2. Clinic
- 6.2.3. Others
- 6.1. Market Analysis, Insights and Forecast - by Type
- 7. South America IV Needle Analysis, Insights and Forecast, 2019-2031
- 7.1. Market Analysis, Insights and Forecast - by Type
- 7.1.1. Conventional Needle
- 7.1.2. Safety Needle
- 7.2. Market Analysis, Insights and Forecast - by Application
- 7.2.1. Hospitals
- 7.2.2. Clinic
- 7.2.3. Others
- 7.1. Market Analysis, Insights and Forecast - by Type
- 8. Europe IV Needle Analysis, Insights and Forecast, 2019-2031
- 8.1. Market Analysis, Insights and Forecast - by Type
- 8.1.1. Conventional Needle
- 8.1.2. Safety Needle
- 8.2. Market Analysis, Insights and Forecast - by Application
- 8.2.1. Hospitals
- 8.2.2. Clinic
- 8.2.3. Others
- 8.1. Market Analysis, Insights and Forecast - by Type
- 9. Middle East & Africa IV Needle Analysis, Insights and Forecast, 2019-2031
- 9.1. Market Analysis, Insights and Forecast - by Type
- 9.1.1. Conventional Needle
- 9.1.2. Safety Needle
- 9.2. Market Analysis, Insights and Forecast - by Application
- 9.2.1. Hospitals
- 9.2.2. Clinic
- 9.2.3. Others
- 9.1. Market Analysis, Insights and Forecast - by Type
- 10. Asia Pacific IV Needle Analysis, Insights and Forecast, 2019-2031
- 10.1. Market Analysis, Insights and Forecast - by Type
- 10.1.1. Conventional Needle
- 10.1.2. Safety Needle
- 10.2. Market Analysis, Insights and Forecast - by Application
- 10.2.1. Hospitals
- 10.2.2. Clinic
- 10.2.3. Others
- 10.1. Market Analysis, Insights and Forecast - by Type
- 11. Competitive Analysis
- 11.1. Global Market Share Analysis 2024
- 11.2. Company Profiles
- 11.2.1 BD
- 11.2.1.1. Overview
- 11.2.1.2. Products
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Financials (Based on Availability)
- 11.2.2 B. Braun
- 11.2.2.1. Overview
- 11.2.2.2. Products
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Financials (Based on Availability)
- 11.2.3 Nipro
- 11.2.3.1. Overview
- 11.2.3.2. Products
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Financials (Based on Availability)
- 11.2.4 Terumo
- 11.2.4.1. Overview
- 11.2.4.2. Products
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Financials (Based on Availability)
- 11.2.5 Novo Nordisk
- 11.2.5.1. Overview
- 11.2.5.2. Products
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Financials (Based on Availability)
- 11.2.6 WEGO
- 11.2.6.1. Overview
- 11.2.6.2. Products
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Financials (Based on Availability)
- 11.2.7 Cardinal Health
- 11.2.7.1. Overview
- 11.2.7.2. Products
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Financials (Based on Availability)
- 11.2.8 Smiths Medical
- 11.2.8.1. Overview
- 11.2.8.2. Products
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Financials (Based on Availability)
- 11.2.9 KDL
- 11.2.9.1. Overview
- 11.2.9.2. Products
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Financials (Based on Availability)
- 11.2.10 Teleflex
- 11.2.10.1. Overview
- 11.2.10.2. Products
- 11.2.10.3. SWOT Analysis
- 11.2.10.4. Recent Developments
- 11.2.10.5. Financials (Based on Availability)
- 11.2.11 Artsana
- 11.2.11.1. Overview
- 11.2.11.2. Products
- 11.2.11.3. SWOT Analysis
- 11.2.11.4. Recent Developments
- 11.2.11.5. Financials (Based on Availability)
- 11.2.12 Ypsomed
- 11.2.12.1. Overview
- 11.2.12.2. Products
- 11.2.12.3. SWOT Analysis
- 11.2.12.4. Recent Developments
- 11.2.12.5. Financials (Based on Availability)
- 11.2.13 Improve Medical
- 11.2.13.1. Overview
- 11.2.13.2. Products
- 11.2.13.3. SWOT Analysis
- 11.2.13.4. Recent Developments
- 11.2.13.5. Financials (Based on Availability)
- 11.2.14
- 11.2.14.1. Overview
- 11.2.14.2. Products
- 11.2.14.3. SWOT Analysis
- 11.2.14.4. Recent Developments
- 11.2.14.5. Financials (Based on Availability)
- 11.2.1 BD
List of Figures
- Figure 1: Global IV Needle Revenue Breakdown (million, %) by Region 2024 & 2032
- Figure 2: Global IV Needle Volume Breakdown (K, %) by Region 2024 & 2032
- Figure 3: North America IV Needle Revenue (million), by Type 2024 & 2032
- Figure 4: North America IV Needle Volume (K), by Type 2024 & 2032
- Figure 5: North America IV Needle Revenue Share (%), by Type 2024 & 2032
- Figure 6: North America IV Needle Volume Share (%), by Type 2024 & 2032
- Figure 7: North America IV Needle Revenue (million), by Application 2024 & 2032
- Figure 8: North America IV Needle Volume (K), by Application 2024 & 2032
- Figure 9: North America IV Needle Revenue Share (%), by Application 2024 & 2032
- Figure 10: North America IV Needle Volume Share (%), by Application 2024 & 2032
- Figure 11: North America IV Needle Revenue (million), by Country 2024 & 2032
- Figure 12: North America IV Needle Volume (K), by Country 2024 & 2032
- Figure 13: North America IV Needle Revenue Share (%), by Country 2024 & 2032
- Figure 14: North America IV Needle Volume Share (%), by Country 2024 & 2032
- Figure 15: South America IV Needle Revenue (million), by Type 2024 & 2032
- Figure 16: South America IV Needle Volume (K), by Type 2024 & 2032
- Figure 17: South America IV Needle Revenue Share (%), by Type 2024 & 2032
- Figure 18: South America IV Needle Volume Share (%), by Type 2024 & 2032
- Figure 19: South America IV Needle Revenue (million), by Application 2024 & 2032
- Figure 20: South America IV Needle Volume (K), by Application 2024 & 2032
- Figure 21: South America IV Needle Revenue Share (%), by Application 2024 & 2032
- Figure 22: South America IV Needle Volume Share (%), by Application 2024 & 2032
- Figure 23: South America IV Needle Revenue (million), by Country 2024 & 2032
- Figure 24: South America IV Needle Volume (K), by Country 2024 & 2032
- Figure 25: South America IV Needle Revenue Share (%), by Country 2024 & 2032
- Figure 26: South America IV Needle Volume Share (%), by Country 2024 & 2032
- Figure 27: Europe IV Needle Revenue (million), by Type 2024 & 2032
- Figure 28: Europe IV Needle Volume (K), by Type 2024 & 2032
- Figure 29: Europe IV Needle Revenue Share (%), by Type 2024 & 2032
- Figure 30: Europe IV Needle Volume Share (%), by Type 2024 & 2032
- Figure 31: Europe IV Needle Revenue (million), by Application 2024 & 2032
- Figure 32: Europe IV Needle Volume (K), by Application 2024 & 2032
- Figure 33: Europe IV Needle Revenue Share (%), by Application 2024 & 2032
- Figure 34: Europe IV Needle Volume Share (%), by Application 2024 & 2032
- Figure 35: Europe IV Needle Revenue (million), by Country 2024 & 2032
- Figure 36: Europe IV Needle Volume (K), by Country 2024 & 2032
- Figure 37: Europe IV Needle Revenue Share (%), by Country 2024 & 2032
- Figure 38: Europe IV Needle Volume Share (%), by Country 2024 & 2032
- Figure 39: Middle East & Africa IV Needle Revenue (million), by Type 2024 & 2032
- Figure 40: Middle East & Africa IV Needle Volume (K), by Type 2024 & 2032
- Figure 41: Middle East & Africa IV Needle Revenue Share (%), by Type 2024 & 2032
- Figure 42: Middle East & Africa IV Needle Volume Share (%), by Type 2024 & 2032
- Figure 43: Middle East & Africa IV Needle Revenue (million), by Application 2024 & 2032
- Figure 44: Middle East & Africa IV Needle Volume (K), by Application 2024 & 2032
- Figure 45: Middle East & Africa IV Needle Revenue Share (%), by Application 2024 & 2032
- Figure 46: Middle East & Africa IV Needle Volume Share (%), by Application 2024 & 2032
- Figure 47: Middle East & Africa IV Needle Revenue (million), by Country 2024 & 2032
- Figure 48: Middle East & Africa IV Needle Volume (K), by Country 2024 & 2032
- Figure 49: Middle East & Africa IV Needle Revenue Share (%), by Country 2024 & 2032
- Figure 50: Middle East & Africa IV Needle Volume Share (%), by Country 2024 & 2032
- Figure 51: Asia Pacific IV Needle Revenue (million), by Type 2024 & 2032
- Figure 52: Asia Pacific IV Needle Volume (K), by Type 2024 & 2032
- Figure 53: Asia Pacific IV Needle Revenue Share (%), by Type 2024 & 2032
- Figure 54: Asia Pacific IV Needle Volume Share (%), by Type 2024 & 2032
- Figure 55: Asia Pacific IV Needle Revenue (million), by Application 2024 & 2032
- Figure 56: Asia Pacific IV Needle Volume (K), by Application 2024 & 2032
- Figure 57: Asia Pacific IV Needle Revenue Share (%), by Application 2024 & 2032
- Figure 58: Asia Pacific IV Needle Volume Share (%), by Application 2024 & 2032
- Figure 59: Asia Pacific IV Needle Revenue (million), by Country 2024 & 2032
- Figure 60: Asia Pacific IV Needle Volume (K), by Country 2024 & 2032
- Figure 61: Asia Pacific IV Needle Revenue Share (%), by Country 2024 & 2032
- Figure 62: Asia Pacific IV Needle Volume Share (%), by Country 2024 & 2032
List of Tables
- Table 1: Global IV Needle Revenue million Forecast, by Region 2019 & 2032
- Table 2: Global IV Needle Volume K Forecast, by Region 2019 & 2032
- Table 3: Global IV Needle Revenue million Forecast, by Type 2019 & 2032
- Table 4: Global IV Needle Volume K Forecast, by Type 2019 & 2032
- Table 5: Global IV Needle Revenue million Forecast, by Application 2019 & 2032
- Table 6: Global IV Needle Volume K Forecast, by Application 2019 & 2032
- Table 7: Global IV Needle Revenue million Forecast, by Region 2019 & 2032
- Table 8: Global IV Needle Volume K Forecast, by Region 2019 & 2032
- Table 9: Global IV Needle Revenue million Forecast, by Type 2019 & 2032
- Table 10: Global IV Needle Volume K Forecast, by Type 2019 & 2032
- Table 11: Global IV Needle Revenue million Forecast, by Application 2019 & 2032
- Table 12: Global IV Needle Volume K Forecast, by Application 2019 & 2032
- Table 13: Global IV Needle Revenue million Forecast, by Country 2019 & 2032
- Table 14: Global IV Needle Volume K Forecast, by Country 2019 & 2032
- Table 15: United States IV Needle Revenue (million) Forecast, by Application 2019 & 2032
- Table 16: United States IV Needle Volume (K) Forecast, by Application 2019 & 2032
- Table 17: Canada IV Needle Revenue (million) Forecast, by Application 2019 & 2032
- Table 18: Canada IV Needle Volume (K) Forecast, by Application 2019 & 2032
- Table 19: Mexico IV Needle Revenue (million) Forecast, by Application 2019 & 2032
- Table 20: Mexico IV Needle Volume (K) Forecast, by Application 2019 & 2032
- Table 21: Global IV Needle Revenue million Forecast, by Type 2019 & 2032
- Table 22: Global IV Needle Volume K Forecast, by Type 2019 & 2032
- Table 23: Global IV Needle Revenue million Forecast, by Application 2019 & 2032
- Table 24: Global IV Needle Volume K Forecast, by Application 2019 & 2032
- Table 25: Global IV Needle Revenue million Forecast, by Country 2019 & 2032
- Table 26: Global IV Needle Volume K Forecast, by Country 2019 & 2032
- Table 27: Brazil IV Needle Revenue (million) Forecast, by Application 2019 & 2032
- Table 28: Brazil IV Needle Volume (K) Forecast, by Application 2019 & 2032
- Table 29: Argentina IV Needle Revenue (million) Forecast, by Application 2019 & 2032
- Table 30: Argentina IV Needle Volume (K) Forecast, by Application 2019 & 2032
- Table 31: Rest of South America IV Needle Revenue (million) Forecast, by Application 2019 & 2032
- Table 32: Rest of South America IV Needle Volume (K) Forecast, by Application 2019 & 2032
- Table 33: Global IV Needle Revenue million Forecast, by Type 2019 & 2032
- Table 34: Global IV Needle Volume K Forecast, by Type 2019 & 2032
- Table 35: Global IV Needle Revenue million Forecast, by Application 2019 & 2032
- Table 36: Global IV Needle Volume K Forecast, by Application 2019 & 2032
- Table 37: Global IV Needle Revenue million Forecast, by Country 2019 & 2032
- Table 38: Global IV Needle Volume K Forecast, by Country 2019 & 2032
- Table 39: United Kingdom IV Needle Revenue (million) Forecast, by Application 2019 & 2032
- Table 40: United Kingdom IV Needle Volume (K) Forecast, by Application 2019 & 2032
- Table 41: Germany IV Needle Revenue (million) Forecast, by Application 2019 & 2032
- Table 42: Germany IV Needle Volume (K) Forecast, by Application 2019 & 2032
- Table 43: France IV Needle Revenue (million) Forecast, by Application 2019 & 2032
- Table 44: France IV Needle Volume (K) Forecast, by Application 2019 & 2032
- Table 45: Italy IV Needle Revenue (million) Forecast, by Application 2019 & 2032
- Table 46: Italy IV Needle Volume (K) Forecast, by Application 2019 & 2032
- Table 47: Spain IV Needle Revenue (million) Forecast, by Application 2019 & 2032
- Table 48: Spain IV Needle Volume (K) Forecast, by Application 2019 & 2032
- Table 49: Russia IV Needle Revenue (million) Forecast, by Application 2019 & 2032
- Table 50: Russia IV Needle Volume (K) Forecast, by Application 2019 & 2032
- Table 51: Benelux IV Needle Revenue (million) Forecast, by Application 2019 & 2032
- Table 52: Benelux IV Needle Volume (K) Forecast, by Application 2019 & 2032
- Table 53: Nordics IV Needle Revenue (million) Forecast, by Application 2019 & 2032
- Table 54: Nordics IV Needle Volume (K) Forecast, by Application 2019 & 2032
- Table 55: Rest of Europe IV Needle Revenue (million) Forecast, by Application 2019 & 2032
- Table 56: Rest of Europe IV Needle Volume (K) Forecast, by Application 2019 & 2032
- Table 57: Global IV Needle Revenue million Forecast, by Type 2019 & 2032
- Table 58: Global IV Needle Volume K Forecast, by Type 2019 & 2032
- Table 59: Global IV Needle Revenue million Forecast, by Application 2019 & 2032
- Table 60: Global IV Needle Volume K Forecast, by Application 2019 & 2032
- Table 61: Global IV Needle Revenue million Forecast, by Country 2019 & 2032
- Table 62: Global IV Needle Volume K Forecast, by Country 2019 & 2032
- Table 63: Turkey IV Needle Revenue (million) Forecast, by Application 2019 & 2032
- Table 64: Turkey IV Needle Volume (K) Forecast, by Application 2019 & 2032
- Table 65: Israel IV Needle Revenue (million) Forecast, by Application 2019 & 2032
- Table 66: Israel IV Needle Volume (K) Forecast, by Application 2019 & 2032
- Table 67: GCC IV Needle Revenue (million) Forecast, by Application 2019 & 2032
- Table 68: GCC IV Needle Volume (K) Forecast, by Application 2019 & 2032
- Table 69: North Africa IV Needle Revenue (million) Forecast, by Application 2019 & 2032
- Table 70: North Africa IV Needle Volume (K) Forecast, by Application 2019 & 2032
- Table 71: South Africa IV Needle Revenue (million) Forecast, by Application 2019 & 2032
- Table 72: South Africa IV Needle Volume (K) Forecast, by Application 2019 & 2032
- Table 73: Rest of Middle East & Africa IV Needle Revenue (million) Forecast, by Application 2019 & 2032
- Table 74: Rest of Middle East & Africa IV Needle Volume (K) Forecast, by Application 2019 & 2032
- Table 75: Global IV Needle Revenue million Forecast, by Type 2019 & 2032
- Table 76: Global IV Needle Volume K Forecast, by Type 2019 & 2032
- Table 77: Global IV Needle Revenue million Forecast, by Application 2019 & 2032
- Table 78: Global IV Needle Volume K Forecast, by Application 2019 & 2032
- Table 79: Global IV Needle Revenue million Forecast, by Country 2019 & 2032
- Table 80: Global IV Needle Volume K Forecast, by Country 2019 & 2032
- Table 81: China IV Needle Revenue (million) Forecast, by Application 2019 & 2032
- Table 82: China IV Needle Volume (K) Forecast, by Application 2019 & 2032
- Table 83: India IV Needle Revenue (million) Forecast, by Application 2019 & 2032
- Table 84: India IV Needle Volume (K) Forecast, by Application 2019 & 2032
- Table 85: Japan IV Needle Revenue (million) Forecast, by Application 2019 & 2032
- Table 86: Japan IV Needle Volume (K) Forecast, by Application 2019 & 2032
- Table 87: South Korea IV Needle Revenue (million) Forecast, by Application 2019 & 2032
- Table 88: South Korea IV Needle Volume (K) Forecast, by Application 2019 & 2032
- Table 89: ASEAN IV Needle Revenue (million) Forecast, by Application 2019 & 2032
- Table 90: ASEAN IV Needle Volume (K) Forecast, by Application 2019 & 2032
- Table 91: Oceania IV Needle Revenue (million) Forecast, by Application 2019 & 2032
- Table 92: Oceania IV Needle Volume (K) Forecast, by Application 2019 & 2032
- Table 93: Rest of Asia Pacific IV Needle Revenue (million) Forecast, by Application 2019 & 2032
- Table 94: Rest of Asia Pacific IV Needle Volume (K) Forecast, by Application 2019 & 2032
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database
Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Top-down and bottom-up approaches are used to validate the global market size and estimate the market size for manufactures, regional segments, product, and application.
Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations
Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence
Additionally, after gathering mixed and scattered data from a wide range of sources, data is triangulated and correlated to come up with estimated figures which are further validated through primary mediums or industry experts, opinion leaders.
Frequently Asked Questions
2. Which companies are prominent players in the IV Needle?
Key companies in the market include BD, B. Braun, Nipro, Terumo, Novo Nordisk, WEGO, Cardinal Health, Smiths Medical, KDL, Teleflex, Artsana, Ypsomed, Improve Medical, .
3. What are the main segments of the IV Needle?
The market segments include Type, Application.
4. Can you provide details about the market size?
The market size is estimated to be USD 3627 million as of 2022.
5. What are some drivers contributing to market growth?
N/A
6. What are the notable trends driving market growth?
N/A
7. Are there any restraints impacting market growth?
N/A
8. Can you provide examples of recent developments in the market?
N/A
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 3480.00, USD 5220.00, and USD 6960.00 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in million and volume, measured in K.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "IV Needle," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the IV Needle report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the IV Needle?
To stay informed about further developments, trends, and reports in the IV Needle, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.